Earlier this week, San Diego startup Gallant introduced $18 million in funding to carry the primary FDA-approved ready-to-use stem cell remedy to veterinary medication. If it passes regulatory muster, it may create a complete new solution to deal with our fur infants.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
